o-Xylene, min. 98%, for synthesis, 2.5 l, glass packaging

5,7-Dibromo-1H-indazole, 95.0%, 5g

2,4-Difluorobenzylsulfonamide, 97.0%, 1g

4,5-Dichloro-2-methylbenzaldehyde, 98%, 100mg

4-Hydroxy-2-(trifluoromethoxy)benzaldehyde, 95.0%, 10g

(T-4)-Difluoro[5-[(4-formyl-3,5-dimethyl-2H-pyrrol-2-ylidene-κN)phenylmethyl]-2,4-dimethyl-1H-pyrrole-3-carboxaldehydato-κN1]boron, 98%, 1g

1,4-Ditosyl-1,4-diazepane, 95%, 100mg

1-Boc-4-Bromo-3-formylindole, 95.0%, 25g

1-Bromo-2,2-dimethoxypropane, 95.0%, 100g

2-(1-N-Boc-Aminomethyl-cyclohexyl)-ethylamine, 96.0%, 250mg

N-Carbobenzoxy-N-methylglycine>97.0%(HPLC)25g

6-methyl-4-(m-tolyl)-5-(3-(p-tolyl)-1,2,4-oxadiazol-5-yl)-3,4-dihydropyrimidine-2(1H)-thione, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid, 97%, 25g